Sanjit Konda, MD
Orthopaedic Surgery · New York, NYNPI 1699970442
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $398,967 of the $575,568 with a category attached, or 69.3%. Stryker accounts for 99.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $233,599, 3.9 times the $59,395 reported in 2020. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $1487.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$575K
- Orthoxel Designated Activity Company$500
- Innovation Technologies Inc$87
- Johnson & Johnson$26
- Arteriocyte Medical Systems, Inc.$26
- Orthofix Medical, Inc.$19
What the payments were for
- Royalty or licence$126,39822%
- Consulting fees$398,96769%
- Travel & lodging$42,7457%
- Food & beverage$7,4581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 382 | $574,910 |
| Orthoxel Designated Activity Company | 1 | $500 |
| Innovation Technologies Inc | 1 | $87 |
| Johnson & Johnson | 1 | $26 |
| Arteriocyte Medical Systems, Inc. | 1 | $26 |
| Orthofix Medical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GAMMA$195,245
- PANGEA$169,778
- AXSOS$146,298
- T2$90,138
- ADAPT$50,574
- AUGMENT INJECTABLE$43,016
- HOFFMANN$40,450
- VARIAX$40,196
- T2 ALPHA$36,844
- PRO$27,663
- INBONE$15,750
- ORTHOLOC 3DI$7,300
- REUNION$5,000
- Actishield$4,366
- MAKO$3,765
- ALLOWRAP$1,200
- ALLOMATRIX$800
- ALLOGRAFT$800
- APEX NAILING SYSTEM$500
- SURPASS EVOLVE$497
How this compares
$575,568 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Teriparatide | 11 | $38,120 |
| Diclofenac Sodium | 44 | $2,676 |
| Naproxen | 216 | $1,534 |
| Gabapentin | 73 | $449 |
| Meloxicam | 86 | $216 |
| Tramadol Hcl | 61 | $120 |
| Oxycodone Hcl | 18 | $100 |
| Cyclobenzaprine Hcl | 19 | $77 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New York
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.